Genfit SA

GENFIT: Half-Year Report of Liquidity Contract with Crédit Industriel et Commercial

13 Jan 2026 12:00:00 By Nasdaq GlobeNewswire

GENFIT Announces 2026 Financial Calendar

07 Jan 2026 12:00:00 By Nasdaq GlobeNewswire

GENFIT: Favorable Phase 1 Safety Profile and Strong Anti-Inflammatory Activity for ACLF Lead Asset G1090N  

06 Jan 2026 12:12:09 By Nasdaq GlobeNewswire

GENFIT: GNS561 Shows Promising Antitumor Activity in Combination Therapy  

10 Dec 2025 12:00:00 By Nasdaq GlobeNewswire

GENFIT Announces Appointment of new Chief Medical Officer

27 Nov 2025 12:00:00 By Nasdaq GlobeNewswire

GENFIT Reports Third Quarter 2025 Financial Information and Provides a Corporate Update  

20 Nov 2025 12:10:00 By Nasdaq GlobeNewswire

GENFIT announces effectiveness of voluntary delisting of American Depositary Shares from Nasdaq Stock Market

20 Nov 2025 12:00:00 By Nasdaq GlobeNewswire

GENFIT Enters Research Collaboration with EVerZom to Advance Exosome-based Regenerative Technology in ACLF

10 Nov 2025 01:45:00 By Nasdaq GlobeNewswire

GENFIT Presents Promising New Preclinical Data on NTZ/G1090N for the Treatment of ACLF at The Liver Meeting® 2025

10 Nov 2025 01:30:00 By Nasdaq GlobeNewswire

GENFIT announces intention to voluntarily delist American Depositary Shares from The Nasdaq Global Select Market

30 Oct 2025 16:00:00 By Nasdaq GlobeNewswire

GENFIT Announces Advances Across its ACLF Pipeline at AASLD The Liver Meeting® 2025

28 Oct 2025 17:10:00 By Nasdaq GlobeNewswire

GENFIT Reports First-Half 2025 Financial Results and Provides Corporate Update

22 Sep 2025 16:10:00 By Nasdaq GlobeNewswire

GENFIT Announces Discontinuation of its VS-01 Program in ACLF: VS-01 Development Refocused on UCD

19 Sep 2025 16:10:00 By Nasdaq GlobeNewswire

Genfit: Half-Year Report of Liquidity Contract with Crédit Industriel et Commercial

08 Jul 2025 16:10:00 By Nasdaq GlobeNewswire

GENFIT: June 17, 2025 Combined Shareholders Meeting Results

17 Jun 2025 14:30:00 By Nasdaq GlobeNewswire

GENFIT Reports First Quarter 2025 Financial Information

22 May 2025 16:10:00 By Nasdaq GlobeNewswire

GENFIT to receive a €26.5 million milestone payment following the approval of pricing and reimbursement of Ipsen’s Iqirvo® in Italy

20 May 2025 16:10:00 By Nasdaq GlobeNewswire

GENFIT: Publication of the 2025 Extra-Financial Performance Report (fiscal year 2024)

14 May 2025 16:10:00 By Nasdaq GlobeNewswire

GENFIT Annual Combined General Meeting of June 17, 2025 — Availability of Preparatory Documents

07 May 2025 16:10:00 By Nasdaq GlobeNewswire

GENFIT to Present Latest ACLF Research at EASL Congress 2025

05 May 2025 01:30:00 By Nasdaq GlobeNewswire